Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | Options Exercise | $61.7K | +330 | +4.63% | $187.06 | 7.46K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$18.3K | -98 | -1.31% | $187.06 | 7.36K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $68.1K | +364 | +4.95% | $187.06 | 7.72K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$17.8K | -95 | -1.23% | $187.06 | 7.63K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $63.8K | +341 | +4.47% | $187.06 | 7.97K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$15.7K | -84 | -1.05% | $187.06 | 7.88K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $46.6K | +249 | +3.16% | $187.06 | 8.13K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$11.4K | -61 | -0.75% | $187.06 | 8.07K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $121K | +645 | +7.99% | $187.06 | 8.72K | Mar 1, 2025 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$29.6K | -158 | -1.81% | $187.06 | 8.56K | Mar 1, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2025 MSU Award | Award | $0 | +1.8K | $0.00 | 1.8K | Mar 1, 2025 | Common Stock | 1.8K | $0.00 | Direct | F1 | |
transaction | AVY | 2025 PU Award | Award | $0 | +1.87K | $0.00 | 1.87K | Mar 1, 2025 | Common Stock | 1.87K | $0.00 | Direct | F2 | |
transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -330 | -100% | $0.00 | 0 | Mar 1, 2025 | Common Stock | 330 | $0.00 | Direct | F3 |
transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -364 | -49.19% | $0.00 | 376 | Mar 1, 2025 | Common Stock | 364 | $0.00 | Direct | F4 |
transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -341 | -33.14% | $0.00 | 688 | Mar 1, 2025 | Common Stock | 341 | $0.00 | Direct | F5 |
transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -249 | -23.94% | $0.00 | 791 | Mar 1, 2025 | Common Stock | 249 | $0.00 | Direct | F6 |
transaction | AVY | 2022 PU Award | Options Exercise | $0 | -645 | -100% | $0.00 | 0 | Mar 1, 2025 | Common Stock | 645 | $0.00 | Direct | F7 |
Id | Content |
---|---|
F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
F2 | Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock. |
F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2021 at 128% of target based on our absolute total stockholder return in excess of 10% during the 2021-2024 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period. |
F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period. |
F7 | Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target. |